Advisor Group’s Forward Pharma A/S American Depositary Shares FWP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$0 Sell
1
-135
-99% -$877 ﹤0.01% 5594
2019
Q3
$1K Buy
136
+66
+94% +$439 ﹤0.01% 5228
2019
Q2
$0 Buy
70
+44
+169% +$329 ﹤0.01% 5491
2019
Q1
$0 Buy
+26
New +$219 ﹤0.01% 5424
2018
Q2
Sell
-2,665
Closed -$40K 5136
2018
Q1
$40K Buy
2,665
+1,194
+81% +$29.1K ﹤0.01% 3253
2017
Q4
$38K Buy
1,471
+735
+100% +$25.7K ﹤0.01% 3286
2017
Q3
$31K Buy
736
+344
+88% +$47.7K ﹤0.01% 3296
2017
Q2
$56K Buy
392
+139
+55% +$19.3K ﹤0.01% 2768
2017
Q1
$38K Buy
253
+78
+45% +$14.7K ﹤0.01% 2936
2016
Q4
$18K Sell
175
-15
-8% -$1.98K ﹤0.01% 3293
2016
Q3
$28K Buy
190
+58
+44% +$8.16K ﹤0.01% 2944
2016
Q2
$16K Buy
+132
New +$17.8K ﹤0.01% 3231

Other funds holding FWP

Advisor Group's FWP Position: Q4 2019 in Review

Advisor Group reduced its Forward Pharma A/S American Depositary Shares (FWP) stake by 99% in Q4 2019, selling an estimated $877 and leaving 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5594.

Advisor Group first reported a position in FWP in Q2 2016 and has held it in 12 quarters since. The position peaked at $56K in Q2 2017. 8 funds tracked by Wall St. Rank hold FWP as of Q4 2019.

  • Advisor Group held 1 share of Forward Pharma A/S American Depositary Shares worth $0 as of Q4 2019.
  • Advisor Group sold 135 Forward Pharma A/S American Depositary Shares shares in Q4 2019, an estimated $877.
  • Forward Pharma A/S American Depositary Shares made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #5594 holding.
  • Advisor Group first reported a position in Forward Pharma A/S American Depositary Shares in Q2 2016 and has held it in 12 quarters since.
  • Advisor Group's Forward Pharma A/S American Depositary Shares position peaked at $56K in Q2 2017.
  • 8 funds tracked by Wall St. Rank held Forward Pharma A/S American Depositary Shares as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.